RecruitingNot ApplicableNCT06975423

Walking Sensation Study

Somatosensory Feedback to Improve Neural Control of Walking in Older Adults

Sponsor

University of Florida

Enrollment

30 participants

Start Date

Sep 8, 2025

Study Type

INTERVENTIONAL

Conditions

Aging Sensory Deficit

Summary

The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins will enhance the automaticity and reduce cognitive demand of walking in older adults with foot sensory impairments, as measured by reduced prefrontal activity, decreased dual-task costs, and lower gait variability.

Eligibility

Min Age: 65 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Active lower-limb neuroprosthesis and a medical device called Inactive lower-limb neuroprosthesis for people with aging and sensory deficit. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 95 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.